动员黏菌素耐药基因3 (mcr-3)的适应度成本:系统综述、流行病学研究和功能分析

IF 10.8 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Lujie Liang, Yaxin Li, Lin Wang, Wenli Wang, Yihao Zhang, Hui Zhao, Yaxuan Wang, Lingxuan Lyu, Jiachen Li, Dianrong Zhou, Zhe Hu, Lizhen Luo, Guanxiu Wang, Jia Wan, Lin Xu, Meisong Li, Min Dai, Meiting Yang, Shun Xiong, Lan-Lan Zhong, Fang Bai, Siyuan Feng, Guo-Bao Tian
{"title":"动员黏菌素耐药基因3 (mcr-3)的适应度成本:系统综述、流行病学研究和功能分析","authors":"Lujie Liang, Yaxin Li, Lin Wang, Wenli Wang, Yihao Zhang, Hui Zhao, Yaxuan Wang, Lingxuan Lyu, Jiachen Li, Dianrong Zhou, Zhe Hu, Lizhen Luo, Guanxiu Wang, Jia Wan, Lin Xu, Meisong Li, Min Dai, Meiting Yang, Shun Xiong, Lan-Lan Zhong, Fang Bai, Siyuan Feng, Guo-Bao Tian","doi":"10.1016/j.ebiom.2025.105923","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The rapid evolution and dissemination of mobilised colistin resistance gene (mcr) family has revealed as a severe threat to the global public health. Nevertheless, dramatic reduction in the prevalence of mcr-1, the major member of mcr family, was observed after the withdrawal of colistin in animal fodder in China since 2017, demonstrating that colistin acts as a selective stress to promote the dissemination of mcr-1. As the second largest lineage, mcr-3 was firstly discovered in 2017 and has been identified from numerous sources. However, whether the spreading of mcr-3 is driven by colistin remains unknown.</p><p><strong>Methods: </strong>To this end, we investigated the global prevalence of mcr-3 from 2005 to 2022 by an up-to-date systematic review, along with a nation-wide epidemiological study to establish the change of mcr-3 prevalence in China before and after 2017. To investigate the fitness cost imposed by MCR-3 upon bacterial host, in vitro and in vivo competitive assays were employed, along with morphological study and fluorescent observation. Moreover, by replacing non-optimal codons with optimal codons, synonymous mutations were introduced into the 5'-coding regions of mcr-3 to study mechanisms accounting for the distinct fitness cost conferred by MCR-1 and MCR-3. Furthermore, by combining AlphaFold and molecular dynamics (MD) simulation, we provided a complete characterisation on the putative lipid A binding pocket localised at the linker domain of MCR-3. Crucially, inhibitors targeting at the putative binding pocket of MCR-1 or MCR-3 were identified from small molecules library using the pipeline of virtual screening.</p><p><strong>Findings: </strong>The global prevalence of mcr-3 increased continuously from 2005 to 2022. The average prevalence was 0.18% during 2005-2014 and rapidly increased to 3.41% during 2020-2022. The prevalence of mcr-3 in China increased from 0.79% in 2016 to 5.87% in 2019. We found that the fitness of mcr-3-bearing Escherichia coli and empty plasmid control was comparable but higher than that of mcr-1-positive strain. Although the putative lipid A binding pocket of MCR-3 was similar to that of in MCR-1, mcr-3 occupies remarkable codon bias at the 5'-end of coding region that disrupted the stability of mRNA, further reduced its protein expression in E. coli, resulting in the low fitness burden of bacterial host. Moreover, the 5'-end codon usage frequency appeared as a critical factor related with the evolution of mcr family. Furthermore, based on the similar lipid A binding pocket among MCR family protein, we identified three MCR inhibitors targeting at such pocket by screening from small-molecule library, which effectively restored the colistin susceptibility of mcr-bearing E. coli.</p><p><strong>Interpretation: </strong>We found that the prevalence of mcr-3 increased continuously during 2016-2019 in China, demonstrating that the withdrawal of colistin in husbandry failed to prevent the dissemination of mcr-3. Our study evidenced that the 5'-end codon bias appeared as a crucial regulator upon the fitness cost conferred by horizontally transferred genes. Most importantly, the putative lipid A binding pocket verified from current study was a promising target site for designing inhibitors against mcr-positive strains.</p><p><strong>Funding: </strong>Natural Science Foundation of China, National Key Research and Development Programme of China.</p>","PeriodicalId":11494,"journal":{"name":"EBioMedicine","volume":"120 ","pages":"105923"},"PeriodicalIF":10.8000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fitness costs of mobilised colistin resistance gene 3 (mcr-3): systematic review, epidemiological study, and functional analysis.\",\"authors\":\"Lujie Liang, Yaxin Li, Lin Wang, Wenli Wang, Yihao Zhang, Hui Zhao, Yaxuan Wang, Lingxuan Lyu, Jiachen Li, Dianrong Zhou, Zhe Hu, Lizhen Luo, Guanxiu Wang, Jia Wan, Lin Xu, Meisong Li, Min Dai, Meiting Yang, Shun Xiong, Lan-Lan Zhong, Fang Bai, Siyuan Feng, Guo-Bao Tian\",\"doi\":\"10.1016/j.ebiom.2025.105923\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The rapid evolution and dissemination of mobilised colistin resistance gene (mcr) family has revealed as a severe threat to the global public health. Nevertheless, dramatic reduction in the prevalence of mcr-1, the major member of mcr family, was observed after the withdrawal of colistin in animal fodder in China since 2017, demonstrating that colistin acts as a selective stress to promote the dissemination of mcr-1. As the second largest lineage, mcr-3 was firstly discovered in 2017 and has been identified from numerous sources. However, whether the spreading of mcr-3 is driven by colistin remains unknown.</p><p><strong>Methods: </strong>To this end, we investigated the global prevalence of mcr-3 from 2005 to 2022 by an up-to-date systematic review, along with a nation-wide epidemiological study to establish the change of mcr-3 prevalence in China before and after 2017. To investigate the fitness cost imposed by MCR-3 upon bacterial host, in vitro and in vivo competitive assays were employed, along with morphological study and fluorescent observation. Moreover, by replacing non-optimal codons with optimal codons, synonymous mutations were introduced into the 5'-coding regions of mcr-3 to study mechanisms accounting for the distinct fitness cost conferred by MCR-1 and MCR-3. Furthermore, by combining AlphaFold and molecular dynamics (MD) simulation, we provided a complete characterisation on the putative lipid A binding pocket localised at the linker domain of MCR-3. Crucially, inhibitors targeting at the putative binding pocket of MCR-1 or MCR-3 were identified from small molecules library using the pipeline of virtual screening.</p><p><strong>Findings: </strong>The global prevalence of mcr-3 increased continuously from 2005 to 2022. The average prevalence was 0.18% during 2005-2014 and rapidly increased to 3.41% during 2020-2022. The prevalence of mcr-3 in China increased from 0.79% in 2016 to 5.87% in 2019. We found that the fitness of mcr-3-bearing Escherichia coli and empty plasmid control was comparable but higher than that of mcr-1-positive strain. Although the putative lipid A binding pocket of MCR-3 was similar to that of in MCR-1, mcr-3 occupies remarkable codon bias at the 5'-end of coding region that disrupted the stability of mRNA, further reduced its protein expression in E. coli, resulting in the low fitness burden of bacterial host. Moreover, the 5'-end codon usage frequency appeared as a critical factor related with the evolution of mcr family. Furthermore, based on the similar lipid A binding pocket among MCR family protein, we identified three MCR inhibitors targeting at such pocket by screening from small-molecule library, which effectively restored the colistin susceptibility of mcr-bearing E. coli.</p><p><strong>Interpretation: </strong>We found that the prevalence of mcr-3 increased continuously during 2016-2019 in China, demonstrating that the withdrawal of colistin in husbandry failed to prevent the dissemination of mcr-3. Our study evidenced that the 5'-end codon bias appeared as a crucial regulator upon the fitness cost conferred by horizontally transferred genes. Most importantly, the putative lipid A binding pocket verified from current study was a promising target site for designing inhibitors against mcr-positive strains.</p><p><strong>Funding: </strong>Natural Science Foundation of China, National Key Research and Development Programme of China.</p>\",\"PeriodicalId\":11494,\"journal\":{\"name\":\"EBioMedicine\",\"volume\":\"120 \",\"pages\":\"105923\"},\"PeriodicalIF\":10.8000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EBioMedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ebiom.2025.105923\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EBioMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ebiom.2025.105923","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:动员型粘菌素耐药基因(mcr)家族的快速进化和传播已被揭示为对全球公共卫生的严重威胁。然而,自2017年以来,在中国动物饲料中停用粘菌素后,观察到mcr家族主要成员mcr-1的流行率急剧下降,这表明粘菌素作为一种选择性应激促进了mcr-1的传播。作为第二大谱系,mcr-3于2017年首次被发现,并从许多来源中被确定。然而,mcr-3的传播是否由粘菌素驱动仍然未知。方法:为此,我们通过最新的系统综述调查了2005年至2022年全球mcr-3的患病率,并进行了一项全国流行病学研究,以确定2017年前后中国mcr-3患病率的变化。为了研究MCR-3对细菌宿主的适应性成本,我们采用了体外和体内竞争实验,并进行了形态学研究和荧光观察。此外,通过用最优密码子替换非最优密码子,将同义突变引入mcr-3的5'编码区,研究MCR-1和mcr-3不同适应度成本的机制。此外,通过结合AlphaFold和分子动力学(MD)模拟,我们提供了位于MCR-3连接域的脂质a结合口袋的完整表征。至关重要的是,针对MCR-1或MCR-3的推定结合口袋的抑制剂是使用虚拟筛选管道从小分子库中鉴定出来的。结果:从2005年到2022年,全球mcr-3患病率持续上升。2005-2014年平均患病率为0.18%,2020-2022年迅速上升至3.41%。中国mcr-3的患病率从2016年的0.79%上升到2019年的5.87%。我们发现携带mcr-3的大肠杆菌和空质粒对照的适应度相当,但高于mcr-1阳性菌株。虽然推测的MCR-3的脂质A结合袋与MCR-1相似,但MCR-3在编码区5'端存在显著的密码子偏置,破坏了mRNA的稳定性,进一步降低了其在大肠杆菌中的蛋白表达,导致细菌宿主的适应度负担较低。此外,5′端密码子的使用频率是影响mcr家族进化的关键因素。此外,基于MCR家族蛋白中类似的脂质A结合口袋,我们从小分子文库中筛选出3种靶向该口袋的MCR抑制剂,有效地恢复了携带MCR的大肠杆菌的粘菌素敏感性。我们发现2016-2019年中国mcr-3的患病率持续上升,这表明在畜牧业中停用粘菌素未能阻止mcr-3的传播。我们的研究证明,5'端密码子偏倚是水平转移基因适应度成本的关键调节因子。最重要的是,本研究证实的脂质A结合袋是设计抗mcr阳性菌株抑制剂的一个有希望的靶点。资助:国家自然科学基金,国家重点研究发展计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Fitness costs of mobilised colistin resistance gene 3 (mcr-3): systematic review, epidemiological study, and functional analysis.

Background: The rapid evolution and dissemination of mobilised colistin resistance gene (mcr) family has revealed as a severe threat to the global public health. Nevertheless, dramatic reduction in the prevalence of mcr-1, the major member of mcr family, was observed after the withdrawal of colistin in animal fodder in China since 2017, demonstrating that colistin acts as a selective stress to promote the dissemination of mcr-1. As the second largest lineage, mcr-3 was firstly discovered in 2017 and has been identified from numerous sources. However, whether the spreading of mcr-3 is driven by colistin remains unknown.

Methods: To this end, we investigated the global prevalence of mcr-3 from 2005 to 2022 by an up-to-date systematic review, along with a nation-wide epidemiological study to establish the change of mcr-3 prevalence in China before and after 2017. To investigate the fitness cost imposed by MCR-3 upon bacterial host, in vitro and in vivo competitive assays were employed, along with morphological study and fluorescent observation. Moreover, by replacing non-optimal codons with optimal codons, synonymous mutations were introduced into the 5'-coding regions of mcr-3 to study mechanisms accounting for the distinct fitness cost conferred by MCR-1 and MCR-3. Furthermore, by combining AlphaFold and molecular dynamics (MD) simulation, we provided a complete characterisation on the putative lipid A binding pocket localised at the linker domain of MCR-3. Crucially, inhibitors targeting at the putative binding pocket of MCR-1 or MCR-3 were identified from small molecules library using the pipeline of virtual screening.

Findings: The global prevalence of mcr-3 increased continuously from 2005 to 2022. The average prevalence was 0.18% during 2005-2014 and rapidly increased to 3.41% during 2020-2022. The prevalence of mcr-3 in China increased from 0.79% in 2016 to 5.87% in 2019. We found that the fitness of mcr-3-bearing Escherichia coli and empty plasmid control was comparable but higher than that of mcr-1-positive strain. Although the putative lipid A binding pocket of MCR-3 was similar to that of in MCR-1, mcr-3 occupies remarkable codon bias at the 5'-end of coding region that disrupted the stability of mRNA, further reduced its protein expression in E. coli, resulting in the low fitness burden of bacterial host. Moreover, the 5'-end codon usage frequency appeared as a critical factor related with the evolution of mcr family. Furthermore, based on the similar lipid A binding pocket among MCR family protein, we identified three MCR inhibitors targeting at such pocket by screening from small-molecule library, which effectively restored the colistin susceptibility of mcr-bearing E. coli.

Interpretation: We found that the prevalence of mcr-3 increased continuously during 2016-2019 in China, demonstrating that the withdrawal of colistin in husbandry failed to prevent the dissemination of mcr-3. Our study evidenced that the 5'-end codon bias appeared as a crucial regulator upon the fitness cost conferred by horizontally transferred genes. Most importantly, the putative lipid A binding pocket verified from current study was a promising target site for designing inhibitors against mcr-positive strains.

Funding: Natural Science Foundation of China, National Key Research and Development Programme of China.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
EBioMedicine
EBioMedicine Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
17.70
自引率
0.90%
发文量
579
审稿时长
5 weeks
期刊介绍: eBioMedicine is a comprehensive biomedical research journal that covers a wide range of studies that are relevant to human health. Our focus is on original research that explores the fundamental factors influencing human health and disease, including the discovery of new therapeutic targets and treatments, the identification of biomarkers and diagnostic tools, and the investigation and modification of disease pathways and mechanisms. We welcome studies from any biomedical discipline that contribute to our understanding of disease and aim to improve human health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信